43 results
8-K
ARVN
Arvinas Inc
24 Jun 24
Departure of Directors or Certain Officers
4:40pm
department in the United States, renegotiated debt obligations to provide the company with enhanced financial flexibility and helped raise over $135
S-3ASR
EX-1.2
ARVN
Arvinas Inc
7 Nov 23
Automatic shelf registration
5:24pm
, the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”), or the U.S. Department of State and including, without limitation … and regulations of the Food and Drug Administration (“FDA”), the U.S. Department of Health and Human Services Office of Inspector General, the Office for Civil
8-K
EX-1.1
k1l0hq 24lsq1orbpd9v
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.1
nnzptv
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.2
jm7t7vdaidg4 y5
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-10.3
zk6f6og1g qa65gy
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
8-K
EX-1.1
ctko88u8 cjiy172uh
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
8-K
EX-99.1
gnnam koav
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am